| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | K63-linked polyubiquitin modification-dependent protein binding | 2.98e-05 | 26 | 139 | 4 | GO:0070530 | |
| Domain | LRRC37AB_C | 2.53e-09 | 4 | 134 | 4 | IPR029423 | |
| Domain | LRRC37AB_C | 2.53e-09 | 4 | 134 | 4 | PF14914 | |
| Domain | LRRC37_N | 2.53e-09 | 4 | 134 | 4 | IPR032754 | |
| Domain | LRRC37 | 2.53e-09 | 4 | 134 | 4 | PF15779 | |
| Domain | LRRC37A/B-like | 2.53e-09 | 4 | 134 | 4 | IPR015753 | |
| Domain | DUF3827 | 5.11e-05 | 2 | 134 | 2 | PF12877 | |
| Domain | DUF3827 | 5.11e-05 | 2 | 134 | 2 | IPR024606 | |
| Domain | Elf-1_N | 1.53e-04 | 3 | 134 | 2 | PF12310 | |
| Domain | TF_Elf_N | 1.53e-04 | 3 | 134 | 2 | IPR022084 | |
| Pubmed | 4.33e-17 | 12 | 148 | 8 | 10433963 | ||
| Pubmed | 1.12e-16 | 13 | 148 | 8 | 17668377 | ||
| Pubmed | The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. | 1.75e-16 | 8 | 148 | 7 | 17588759 | |
| Pubmed | 2.60e-15 | 10 | 148 | 7 | 17984056 | ||
| Pubmed | 3.68e-14 | 13 | 148 | 7 | 7739628 | ||
| Pubmed | Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. | 4.11e-13 | 17 | 148 | 7 | 11245978 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | EVL NCOA6 GAPVD1 DNAJC13 PHRF1 DAB2 KDM3B ISL2 MCM4 HUWE1 GTF2IRD1 PNISR ZC3H11A BRPF1 CCNL1 ELF2 HSF1 PCM1 MRTFA PPP6R3 SON | 1.77e-11 | 774 | 148 | 21 | 15302935 |
| Pubmed | 5.36e-10 | 101 | 148 | 9 | 10997877 | ||
| Pubmed | ARHGAP32 DNAJC13 ZFYVE16 VEZT SIPA1L3 NAGLU KIAA1549 TNS2 TAB2 HUWE1 NCKAP5L CEP350 TOX4 NUP155 SSH3 MTMR3 PPP1R37 PHLPP1 MPHOSPH9 TRIM36 KNL1 PPP6R3 | 7.43e-10 | 1049 | 148 | 22 | 27880917 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NCOA6 RARG RHBDF2 PPRC1 SIPA1L3 NAGLU KDM3B AMBRA1 HUWE1 REV3L MED13L SRCAP GTF2IRD1 ATP13A2 ZC3H11A IGF1R SHANK2 CHST15 BTBD7 NCAPD2 MTMR3 NAV2 | 1.93e-09 | 1105 | 148 | 22 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | NCOA6 ARHGAP32 DAB2 SYNGAP1 ZNF469 NUP155 ZNF532 SQSTM1 EIF4EBP1 NFKBIL1 BSN MRTFA TP73 SON | 5.17e-09 | 430 | 148 | 14 | 35044719 |
| Pubmed | NCOA6 GAPVD1 PHRF1 KDM3B KIAA1549 AMBRA1 SRCIN1 NACAD NPLOC4 NUP155 ZNF532 NCAPD2 NAV2 BSN PPP6R3 | 9.13e-09 | 529 | 148 | 15 | 14621295 | |
| Pubmed | FOXO1 KLF8 DUX4L9 KDM3B ISL2 POU2F2 E2F2 DUX4L2 SRCAP TOX4 MTF1 BTBD7 BRPF1 ELF2 HSF1 DUX4L4 MRTFA NOBOX | 1.18e-08 | 808 | 148 | 18 | 20412781 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | FOXO1 BAK1 E2F2 TAB2 HUWE1 SRCAP NCKAP5L ZZZ3 SQSTM1 BSN NXF1 PCM1 TP73 KNL1 PPP6R3 | 3.68e-08 | 588 | 148 | 15 | 38580884 |
| Pubmed | 6.48e-08 | 10 | 148 | 4 | 23064749 | ||
| Pubmed | A census of human transcription factors: function, expression and evolution. | FOXO1 KLF8 RARG KIAA1549 ISL2 POU2F2 E2F2 SIX1 ZC3H11A TOX4 ZZZ3 MTF1 ELF2 ELF4 HSF1 ZNF541 TP73 NOBOX | 6.90e-08 | 908 | 148 | 18 | 19274049 |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | SECISBP2L FOXO1 EVL GAPVD1 BMP2K DAB2 KDM3B WDR81 TAB2 NCKAP5L PNISR CEP350 SHANK2 SQSTM1 BTBD7 MPHOSPH9 HEATR5B MRTFA PPP6R3 | 1.00e-07 | 1038 | 148 | 19 | 26673895 |
| Pubmed | GAPVD1 DNAJC13 ZFYVE16 HUWE1 TOX4 ZZZ3 ZNF532 SQSTM1 NXF1 PCM1 MRTFA KNL1 | 2.60e-07 | 418 | 148 | 12 | 34709266 | |
| Pubmed | DAB2 MCM4 HUWE1 ZXDA ZC3H11A SQSTM1 SSH3 NCAPD2 NAV2 PCM1 MRTFA PPP6R3 SON | 2.69e-07 | 503 | 148 | 13 | 16964243 | |
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 22419166 | ||
| Pubmed | 3.01e-07 | 4 | 148 | 3 | 17911620 | ||
| Pubmed | The homeobox transcription factor DUXBL controls exit from totipotency. | 3.01e-07 | 4 | 148 | 3 | 38509386 | |
| Pubmed | ZBTB2 VEZT PHRF1 KIAA1549 AMBRA1 E2F2 REV3L SRCAP NCKAP5L ZNF469 ZZZ3 SQSTM1 BRPF1 RTL9 NFKBIL1 PCM1 TP73 KNL1 SON | 3.04e-07 | 1116 | 148 | 19 | 31753913 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 4.37e-07 | 218 | 148 | 9 | 33378226 | |
| Pubmed | 5.69e-07 | 225 | 148 | 9 | 12168954 | ||
| Pubmed | NCOA6 GAPVD1 MAP1B KDM3B HUWE1 SRCAP ZC3H11A TOX4 ZZZ3 ICAM5 NCAPD2 PCM1 PPP6R3 | 7.20e-07 | 549 | 148 | 13 | 38280479 | |
| Pubmed | 7.50e-07 | 5 | 148 | 3 | 20063414 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | FOXO1 NCOA6 ARHGAP32 GAPVD1 MAP1B SIPA1L3 BRSK2 KDM3B TAB2 NCKAP5L CEP350 IGF1R SQSTM1 NAV2 MPHOSPH9 PCM1 | 9.06e-07 | 861 | 148 | 16 | 36931259 |
| Pubmed | Docking motif-guided mapping of the interactome of protein phosphatase-1. | 1.24e-06 | 80 | 148 | 6 | 19389623 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | COL5A1 EVL KLF8 DNAJC13 PDE9A RHBDF2 MAP1B VEZT SIPA1L3 TMEM63B SRCIN1 HUWE1 GTF2IRD1 SNX29 NPLOC4 ZC3H11A IGF1R SHANK2 ZNF532 CROCC PCM1 | 1.46e-06 | 1489 | 148 | 21 | 28611215 |
| Pubmed | New loci associated with central cornea thickness include COL5A1, AKAP13 and AVGR8. | 1.50e-06 | 6 | 148 | 3 | 20719862 | |
| Pubmed | The transcription factor Duxbl mediates elimination of pre-T cells that fail β-selection. | 2.61e-06 | 7 | 148 | 3 | 30765463 | |
| Pubmed | 3.41e-06 | 209 | 148 | 8 | 36779422 | ||
| Pubmed | DMXL2 ZFYVE16 BMP2K DAB2 SNX29 SQSTM1 PPP1R37 HEATR5B TRIM36 | 3.98e-06 | 285 | 148 | 9 | 34369648 | |
| Pubmed | COL5A1 GAPVD1 MAP1B PHRF1 MCM4 HUWE1 ZC3H11A NUP155 NCAPD2 NXF1 PCM1 PPP6R3 SON | 4.82e-06 | 653 | 148 | 13 | 22586326 | |
| Pubmed | 6.10e-06 | 105 | 148 | 6 | 9628581 | ||
| Pubmed | MAPK8IP1 EVL ARHGAP32 DMXL2 MAP1B VEZT BRSK2 DAG1 SRCIN1 HUWE1 NACAD SYNGAP1 SHANK2 CAMKV SQSTM1 BSN PCM1 | 7.68e-06 | 1139 | 148 | 17 | 36417873 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 8.83e-06 | 170 | 148 | 7 | 23314748 | |
| Pubmed | SECISBP2L ARHGAP32 DMXL2 ZBTB2 SIPA1L3 BRSK2 MSL2 CEP350 TOX4 TTBK1 TRPM3 | 9.29e-06 | 493 | 148 | 11 | 15368895 | |
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 1.06e-05 | 322 | 148 | 9 | 39098523 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | GAPVD1 MAP1B ZFYVE16 KDM3B MCM4 SRCAP SNX29 NPLOC4 ZC3H11A TOX4 ELF2 PCM1 KNL1 PPP6R3 SON | 1.16e-05 | 934 | 148 | 15 | 33916271 |
| Pubmed | Dopaminergic control of autophagic-lysosomal function implicates Lmx1b in Parkinson's disease. | 1.32e-05 | 34 | 148 | 4 | 25915474 | |
| Pubmed | Autophagy promotes primary ciliogenesis by removing OFD1 from centriolar satellites. | 1.62e-05 | 12 | 148 | 3 | 24089205 | |
| Pubmed | 1.66e-05 | 125 | 148 | 6 | 29467281 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 28655741 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24314652 | ||
| Pubmed | Regulation of HSF1-responsive gene expression by N-terminal truncated form of p73alpha. | 1.80e-05 | 2 | 148 | 2 | 15081420 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 24145033 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26423274 | ||
| Pubmed | Susceptibility to apoptosis in insulin-like growth factor-I receptor-deficient brown adipocytes. | 1.80e-05 | 2 | 148 | 2 | 15356271 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 38267912 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 25101860 | ||
| Pubmed | Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. | 1.80e-05 | 2 | 148 | 2 | 18159944 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 26884344 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 29421153 | ||
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 20485516 | ||
| Pubmed | Genetic interaction implicates iRhom2 in the regulation of EGF receptor signalling in mice. | 1.80e-05 | 2 | 148 | 2 | 25395669 | |
| Pubmed | 1.80e-05 | 2 | 148 | 2 | 32590022 | ||
| Pubmed | E2F2 is upregulated by the ERK pathway and regulates decidualization via MCM4. | 1.80e-05 | 2 | 148 | 2 | 37028609 | |
| Pubmed | Tissue-specific role of RHBDF2 in cutaneous wound healing and hyperproliferative skin disease. | 1.80e-05 | 2 | 148 | 2 | 29116018 | |
| Pubmed | EVL GAPVD1 BMP2K SIPA1L3 DAB2 DAG1 AREG TOX4 SQSTM1 NAV2 PCM1 PPP6R3 | 1.86e-05 | 634 | 148 | 12 | 34591612 | |
| Pubmed | A germline-specific class of small RNAs binds mammalian Piwi proteins. | BMP2K LRRC37A2 BRSK2 NPLOC4 MTF1 SQSTM1 NCAPD2 MTMR3 BSN SON | 2.48e-05 | 450 | 148 | 10 | 16751776 |
| Pubmed | 3.31e-05 | 15 | 148 | 3 | 35727972 | ||
| Pubmed | 3.31e-05 | 15 | 148 | 3 | 30071041 | ||
| Pubmed | 3.45e-05 | 210 | 148 | 7 | 16565220 | ||
| Pubmed | MAPK8IP1 EVL ARHGAP32 DMXL2 DNAJC13 MAP1B SIPA1L3 BRSK2 KIAA1549 SRCIN1 SYNGAP1 SHANK2 CAMKV ICAM5 NCAN BSN CROCC PCM1 | 4.00e-05 | 1431 | 148 | 18 | 37142655 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | GAPVD1 BMP2K LRRC37A3 DAB2 RAET1E TRIM6 ATP13A2 ICAM5 SSH3 MPHOSPH9 SUCO PCM1 MRTFA TP73 | 4.39e-05 | 925 | 148 | 14 | 28986522 |
| Pubmed | ARHGAP32 DAB2 NCKAP5L PNISR MSL2 CEP350 TOX4 KIAA1549L NAV2 MPHOSPH9 | 4.73e-05 | 486 | 148 | 10 | 20936779 | |
| Pubmed | 4.91e-05 | 17 | 148 | 3 | 26627310 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 16181796 | ||
| Pubmed | Netrin-1 induces apoptosis in human cervical tumor cells via the TAp73alpha tumor suppressor. | 5.38e-05 | 3 | 148 | 2 | 18922894 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 11013086 | ||
| Pubmed | p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control. | 5.38e-05 | 3 | 148 | 2 | 26554827 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 34922539 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 18442140 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 24135282 | ||
| Pubmed | Coactivator ASC-2 mediates heat shock factor 1-mediated transactivation dependent on heat shock. | 5.38e-05 | 3 | 148 | 2 | 14960326 | |
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 21233848 | ||
| Pubmed | 5.38e-05 | 3 | 148 | 2 | 23360921 | ||
| Pubmed | HUWE1 controls MCL1 stability to unleash AMBRA1-induced mitophagy. | 5.38e-05 | 3 | 148 | 2 | 31434979 | |
| Pubmed | IGF-1 Receptor Modulates FoxO1-Mediated Tamoxifen Response in Breast Cancer Cells. | 5.38e-05 | 3 | 148 | 2 | 28096479 | |
| Pubmed | 5.48e-05 | 226 | 148 | 7 | 31452512 | ||
| Pubmed | FOXO1 RARG POU2F2 E2F2 SIX1 GTF2IRD1 TOX4 ZZZ3 ZNF532 MTF1 SQSTM1 BRPF1 | 5.50e-05 | 709 | 148 | 12 | 22988430 | |
| Pubmed | Werner helicase-interacting protein 1 binds polyubiquitin via its zinc finger domain. | 6.23e-05 | 50 | 148 | 4 | 17550899 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 6.47e-05 | 232 | 148 | 7 | 25515538 | |
| Pubmed | 6.60e-05 | 407 | 148 | 9 | 12693553 | ||
| Pubmed | MAPK8IP1 ARHGAP32 DMXL2 DNAJC13 SIPA1L3 WDR81 HUWE1 SYNGAP1 SHANK2 CAMKV ICAM5 NCAN BSN PCM1 | 6.74e-05 | 963 | 148 | 14 | 28671696 | |
| Pubmed | GAPVD1 ZFYVE16 VEZT KDM3B HUWE1 NCKAP5L CEP350 SQSTM1 MPHOSPH9 CROCC PCM1 KNL1 | 7.54e-05 | 733 | 148 | 12 | 34672954 | |
| Pubmed | TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. | 8.16e-05 | 20 | 148 | 3 | 25127057 | |
| Pubmed | 8.16e-05 | 103 | 148 | 5 | 10819331 | ||
| Pubmed | 8.55e-05 | 104 | 148 | 5 | 9205841 | ||
| Pubmed | 8.55e-05 | 104 | 148 | 5 | 10470851 | ||
| Pubmed | 9.32e-05 | 246 | 148 | 7 | 15345747 | ||
| Pubmed | NCOA6 ARHGAP32 LRRC37A3 KDM3B MUC16 TAB2 REV3L CEP350 ASXL3 BSN KNL1 | 9.62e-05 | 638 | 148 | 11 | 31182584 | |
| Pubmed | 1.06e-04 | 251 | 148 | 7 | 29778605 | ||
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 30022999 | ||
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 23078915 | ||
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 19147168 | ||
| Pubmed | SCOP/PHLPP1β mediates circadian regulation of long-term recognition memory. | 1.07e-04 | 4 | 148 | 2 | 27686624 | |
| Pubmed | 1.07e-04 | 4 | 148 | 2 | 22814818 | ||
| Interaction | PHF21A interactions | KLF8 GAPVD1 DNAJC13 ZFYVE16 HUWE1 NCKAP5L TOX4 ZZZ3 SQSTM1 PCM1 MRTFA KNL1 | 5.45e-06 | 343 | 141 | 12 | int:PHF21A |
| Interaction | PLK1 interactions | GAPVD1 MAP1B GRB7 TNS2 MCM4 NUP155 SQSTM1 MTMR3 PHLPP1 TRIM36 HSF1 PCM1 TP73 PPP6R3 | 1.42e-05 | 510 | 141 | 14 | int:PLK1 |
| Interaction | YWHAG interactions | FOXO1 NCOA6 ARHGAP32 GAPVD1 SIPA1L3 KDM3B TNS2 TAB2 HUWE1 NCKAP5L MSL2 SYNGAP1 CEP350 TTBK1 IGF1R SQSTM1 MTMR3 NAV2 MPHOSPH9 SUCO PCM1 PPP6R3 SON | 1.83e-05 | 1248 | 141 | 23 | int:YWHAG |
| Interaction | CEP135 interactions | ARHGAP32 SIPA1L3 NCKAP5L CEP350 NUP155 SQSTM1 RTL9 MPHOSPH9 TRIM36 PCM1 | 2.22e-05 | 272 | 141 | 10 | int:CEP135 |
| Interaction | NUDC interactions | FOXO1 MAP1B AMBRA1 DUX4 HUWE1 SYNGAP1 ZNF532 PHLPP1 HSF1 HYDIN NXF1 | 2.58e-05 | 337 | 141 | 11 | int:NUDC |
| Interaction | POLH interactions | 2.74e-05 | 84 | 141 | 6 | int:POLH | |
| Interaction | YWHAZ interactions | FOXO1 EVL ARHGAP32 DMXL2 GAPVD1 SIPA1L3 TAB2 HUWE1 NCKAP5L MSL2 SYNGAP1 IGF1R CAMKV SQSTM1 ASXL3 SSH3 MTMR3 NAV2 MPHOSPH9 HSF1 SUCO NXF1 PCM1 | 4.34e-05 | 1319 | 141 | 23 | int:YWHAZ |
| Interaction | RCOR1 interactions | DNAJC13 ZFYVE16 HUWE1 NCKAP5L TOX4 ZZZ3 SQSTM1 NCAPD2 NXF1 PCM1 MRTFA KNL1 PPP6R3 | 4.49e-05 | 494 | 141 | 13 | int:RCOR1 |
| Interaction | PSMC3 interactions | KLF8 GAPVD1 MAP1B ZFYVE16 AMBRA1 HUWE1 ZZZ3 SQSTM1 NCAPD2 ELF2 HSF1 NXF1 | 4.55e-05 | 425 | 141 | 12 | int:PSMC3 |
| Interaction | SQSTM1 interactions | FOXO1 ARHGAP32 GAPVD1 DNAJC13 MAP1B ZFYVE16 BMP2K SIPA1L3 WDR81 AMBRA1 TAB2 HUWE1 CEP350 NUP155 CAMKV SQSTM1 IRAK4 PHLPP1 CROCC HEATR5B NXF1 PPP6R3 | 6.16e-05 | 1257 | 141 | 22 | int:SQSTM1 |
| Interaction | KPNA2 interactions | FOXO1 GAPVD1 ZBTB2 MAP1B MCM4 HUWE1 GTF2IRD1 NUP155 SQSTM1 ASXL3 NCAPD2 HSF1 NXF1 | 7.42e-05 | 519 | 141 | 13 | int:KPNA2 |
| Interaction | RGPD6 interactions | 8.02e-05 | 33 | 141 | 4 | int:RGPD6 | |
| Cytoband | 4q35.2 | 2.84e-10 | 27 | 148 | 6 | 4q35.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q35 | 4.89e-09 | 117 | 148 | 8 | chr4q35 | |
| Cytoband | 6q25.1 | 2.55e-04 | 38 | 148 | 3 | 6q25.1 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 2.16e-08 | 92 | 92 | 8 | 521 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 3.84e-05 | 181 | 92 | 7 | 694 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 5.17e-04 | 31 | 92 | 3 | 81 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L DMXL2 GAPVD1 DNAJC13 MAP1B ZFYVE16 BMP2K KDM3B TAB2 REV3L MED13L PNISR CEP350 IGF1R ZZZ3 MTMR3 PHLPP1 MPHOSPH9 SUCO MRTFA SON | 1.27e-08 | 856 | 146 | 21 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | FOXO1 GAPVD1 PPRC1 REV3L MED13L PNISR CEP350 ZZZ3 PHLPP1 ELF2 SUCO | 1.02e-06 | 300 | 146 | 11 | M8702 |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.34e-07 | 198 | 141 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-07 | 199 | 141 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-5|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.40e-06 | 174 | 141 | 7 | 73e1ad4007d94fca25ed7c6fbe5d205d4e1b8a3b | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-06 | 196 | 141 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.19e-06 | 197 | 141 | 7 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.30e-06 | 198 | 141 | 7 | 85f424cd9bb3117c9e322031024aabb87696ce47 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.41e-06 | 199 | 141 | 7 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.41e-06 | 199 | 141 | 7 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 3.53e-06 | 200 | 141 | 7 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-neuro-epithelial-EECs|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 162 | 141 | 6 | 478cf560ef33c5c324142c76417447d4a571a2c9 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.40e-05 | 164 | 141 | 6 | fb18b863152fb3109e2224c791c84c6371680a4e | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-05 | 167 | 141 | 6 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4/8-lo-Cycling_T|Lung / Manually curated celltypes from each tissue | 2.08e-05 | 176 | 141 | 6 | a40dfd8c4ba16757ff929b2f03a0628acf334de4 | |
| ToppCell | Mild/Remission-B_naive-12|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.32e-05 | 107 | 141 | 5 | 1ab09acb66e4282688fd1f6782a4009f4ea18c41 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.59e-05 | 183 | 141 | 6 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.93e-05 | 187 | 141 | 6 | 6e5c38425b6b1d4774f8dcea7e146f1eab785c3e | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.93e-05 | 187 | 141 | 6 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.93e-05 | 187 | 141 | 6 | 43ef900b76f3c38bd8ce9858201124130c743d56 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.93e-05 | 187 | 141 | 6 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.02e-05 | 188 | 141 | 6 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 192 | 141 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.49e-05 | 193 | 141 | 6 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.49e-05 | 193 | 141 | 6 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c14-MKI67-CCL5_h|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.49e-05 | 193 | 141 | 6 | cf680afddc08b6481f1b3eee9c57acfaebeac6f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.49e-05 | 193 | 141 | 6 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 194 | 141 | 6 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-05 | 195 | 141 | 6 | c6e31038be2463f1601d52c82efa4e9facb8228f | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.70e-05 | 195 | 141 | 6 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 3.70e-05 | 195 | 141 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 195 | 141 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.70e-05 | 195 | 141 | 6 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 195 | 141 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-05 | 196 | 141 | 6 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.92e-05 | 197 | 141 | 6 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.92e-05 | 197 | 141 | 6 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | (3)_DC_Monocyte_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.03e-05 | 198 | 141 | 6 | e2b89f6d7c0007ccab62495cd543fe0e5513a9a4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.14e-05 | 199 | 141 | 6 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 4.14e-05 | 199 | 141 | 6 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.26e-05 | 200 | 141 | 6 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.26e-05 | 200 | 141 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Neuronal-Cortical_neuron|10w / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-05 | 200 | 141 | 6 | 68c90376e2779434e4ad8dc6dd3b44baa700e2f4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Meis2-Meis2_Adamts19|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.82e-05 | 69 | 141 | 4 | 130b1a56afe6aee01cde56cb983cbc2c41861bb4 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Meis2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.82e-05 | 69 | 141 | 4 | 6568fcefcc0dca211f2acf6e4066f795489e758d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 143 | 141 | 5 | 360a2ea8b64e3b9084f4c4cb8beb0d44106b9edb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 143 | 141 | 5 | 605532fc0f32979b306cbb58f8796df7d6b24828 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-05 | 143 | 141 | 5 | 5cc59deb5a8af8095c1581e585eaeeecdd938621 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 155 | 141 | 5 | 82e602f31981c6b48abff2a04b2ab5d26d4462a2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.35e-04 | 155 | 141 | 5 | 979c1d53b435a82c57d16707eed8ba7346326866 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 167 | 141 | 5 | 108ae6221c6edc63c0ec42c42471b3a15a594043 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 168 | 141 | 5 | 9b8a74abb83c64f0b5829dcb4275f722c82b45dc | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 168 | 141 | 5 | b87fc63f9e35dfcfc46cb129ea569e73c5e018bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 168 | 141 | 5 | b96a48552f4236a95bbcdce2f1b05041086d7101 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 168 | 141 | 5 | 4b152b8d0f4a66faf664dfacb7914b18d60ce64a | |
| ToppCell | PND14-Immune-Immune_Myeloid-Dendritic-cDC1-cDC1_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.96e-04 | 168 | 141 | 5 | c3169ad8f4130ef18777ed86770bb722ffb5db85 | |
| ToppCell | Mild/Remission-B_naive-4|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.02e-04 | 169 | 141 | 5 | c3a6179a64589a370108fea809b157839347759c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-04 | 171 | 141 | 5 | 1854a777d9eb9d3fc3ed3632332a6f89ce8131da | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.19e-04 | 172 | 141 | 5 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.31e-04 | 174 | 141 | 5 | 68914ec843f58ecff3e6412544a341daf8a01cac | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 174 | 141 | 5 | 268be5e7d2a18b866770b7cdb966c3958c7e6534 | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_proliferating_2|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-04 | 174 | 141 | 5 | a75ba49ccea6bd3d78ada1092b46deb5202c58a5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 174 | 141 | 5 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 174 | 141 | 5 | 4cdf2eedc28d88d18241ee390092426fdf849e79 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 2.31e-04 | 174 | 141 | 5 | e4c8da80eca07e4396f57dad212f76c2eca4c1bd | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 2.37e-04 | 175 | 141 | 5 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Promyelocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.43e-04 | 176 | 141 | 5 | ee33d7077a92c1fd371081e7c990c7266e711957 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-04 | 177 | 141 | 5 | f925a15d2162d166a5b60edac3517c6b2d6cfbea | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 178 | 141 | 5 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.57e-04 | 178 | 141 | 5 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.70e-04 | 180 | 141 | 5 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 181 | 141 | 5 | 4e81ec1580e9acb22c32c465eb46f83d1e9e424e | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 181 | 141 | 5 | ad30c01290fb98adbd0caed301a584761212c977 | |
| ToppCell | droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 181 | 141 | 5 | a53f05c4c47465ee62e353716456bd09ab464b23 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 181 | 141 | 5 | 3a3268a4dff8ffcb79e09f46490e138c96f8d916 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 184 | 141 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_int|lung / Disease (COVID-19 only), tissue and cell type | 2.99e-04 | 184 | 141 | 5 | 480595a0e2e6aa2a77b7daa36490ae3af3d8dfee | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.99e-04 | 184 | 141 | 5 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 184 | 141 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 184 | 141 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.06e-04 | 185 | 141 | 5 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-04 | 185 | 141 | 5 | ea3ff0bd3f312bd2e93227ecf6ed577366aab3e0 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.06e-04 | 185 | 141 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 3.06e-04 | 185 | 141 | 5 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-04 | 185 | 141 | 5 | 1b8e3ddb91797f84e4b15d2457b0c008e5be50db | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-04 | 185 | 141 | 5 | 02cbf492bc40abebaa93a3a208888afae72fbe06 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 3.06e-04 | 185 | 141 | 5 | df85ff34b796b403f2d0741771e9592e03657f6a | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-04 | 186 | 141 | 5 | 39e475a3c167b33daa63b0c1bfa32451c5f46635 | |
| ToppCell | COVID-19-lung-Plasma_cells_PRDM1/BLIMP_hi|lung / Disease (COVID-19 only), tissue and cell type | 3.14e-04 | 186 | 141 | 5 | 66676d9395172de5707e204826a1c9f73b448cca | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 186 | 141 | 5 | 2cae34336f184f971f7c8684cc27c23a4e7369ed | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.14e-04 | 186 | 141 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 186 | 141 | 5 | 90d53c2597a9f3a2b39afba75adfc54f1ca0a4db | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.14e-04 | 186 | 141 | 5 | 02418c50fdcca549bf73dedf6199ab4a27862a9b | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.14e-04 | 186 | 141 | 5 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-04 | 187 | 141 | 5 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 187 | 141 | 5 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.22e-04 | 187 | 141 | 5 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.22e-04 | 187 | 141 | 5 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 3.30e-04 | 188 | 141 | 5 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 3.30e-04 | 188 | 141 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | COVID-19-kidney-CD-PC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.30e-04 | 188 | 141 | 5 | 8f9996c3f3b27efaaae8960a66af77412de9c7ef | |
| Drug | Propoxycaine hydrochloride [550-83-4]; Down 200; 12uM; PC3; HT_HG-U133A | 4.78e-06 | 192 | 148 | 9 | 7155_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; MCF7; HT_HG-U133A | 6.39e-06 | 199 | 148 | 9 | 1703_DN | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; MCF7; HT_HG-U133A | 6.66e-06 | 200 | 148 | 9 | 2769_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.59e-05 | 170 | 148 | 8 | 1050_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.73e-05 | 172 | 148 | 8 | 1072_DN | |
| Drug | trichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.04e-05 | 176 | 148 | 8 | 981_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.60e-05 | 182 | 148 | 8 | 3887_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 3.95e-05 | 193 | 148 | 8 | 5600_UP | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; HL60; HG-U133A | 3.95e-05 | 193 | 148 | 8 | 1715_UP | |
| Drug | Leucomisine [17946-87-1]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 4.10e-05 | 194 | 148 | 8 | 6767_DN | |
| Drug | semduramicin | 4.20e-05 | 2 | 148 | 2 | CID000071327 | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; PC3; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 4624_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; PC3; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 7401_UP | |
| Drug | Sulfaguanidine [57-67-0]; Down 200; 18.6uM; PC3; HG-U133A | 4.73e-05 | 198 | 148 | 8 | 1913_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 3292_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A | 5.08e-05 | 200 | 148 | 8 | 5996_DN | |
| Disease | Intellectual Disability | KLF8 MAP1B NAGLU BRSK2 KDM3B MED13L DCC SYNGAP1 SHANK2 TRPM3 MTF1 | 8.75e-06 | 447 | 138 | 11 | C3714756 |
| Disease | nephroblastoma (is_implicated_in) | 3.51e-05 | 14 | 138 | 3 | DOID:2154 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 7.77e-05 | 93 | 138 | 5 | C1535926 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 9.94e-05 | 157 | 138 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | EVL NCOA6 RARG LRRC37A2 GRB7 INPP4B AREG ZC3H11A IGF1R LRRC37A ZNF532 ICAM5 MTMR3 ZNF541 TP73 | 1.58e-04 | 1074 | 138 | 15 | C0006142 |
| Disease | Alzheimer disease, educational attainment | 1.69e-04 | 247 | 138 | 7 | EFO_0011015, MONDO_0004975 | |
| Disease | Alveolar rhabdomyosarcoma | 2.15e-04 | 5 | 138 | 2 | C0206655 | |
| Disease | Breast Carcinoma | EVL LRRC37A2 GRB7 INPP4B AREG ZC3H11A IGF1R LRRC37A ICAM5 TP73 | 2.30e-04 | 538 | 138 | 10 | C0678222 |
| Disease | eye measurement | 2.70e-04 | 27 | 138 | 3 | EFO_0004731 | |
| Disease | glucose measurement | 4.36e-04 | 380 | 138 | 8 | EFO_0004468 | |
| Disease | Profound Mental Retardation | 5.06e-04 | 139 | 138 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 5.06e-04 | 139 | 138 | 5 | C0025363 | |
| Disease | Mental deficiency | 5.06e-04 | 139 | 138 | 5 | C0917816 | |
| Disease | Congenital Hydrocephalus | 5.97e-04 | 8 | 138 | 2 | C0020256 | |
| Disease | Mammary Carcinoma, Human | 8.43e-04 | 525 | 138 | 9 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 8.43e-04 | 525 | 138 | 9 | C1257931 | |
| Disease | Mammary Neoplasms | 8.66e-04 | 527 | 138 | 9 | C1458155 | |
| Disease | prostatic hypertrophy (is_marker_for) | 1.16e-03 | 11 | 138 | 2 | DOID:11132 (is_marker_for) | |
| Disease | cryptorchidism (biomarker_via_orthology) | 1.16e-03 | 11 | 138 | 2 | DOID:11383 (biomarker_via_orthology) | |
| Disease | quality of life during menstruation measurement, decreased attention | 1.39e-03 | 12 | 138 | 2 | EFO_0009366, NCIT_C117245 | |
| Disease | obsolete_red blood cell distribution width | DNAJC13 BMP2K LRRC37A2 TMEM63B E2F2 SLFN14 NPLOC4 INPP4B ZC3H11A IGF1R SQSTM1 CD300LG LRRC37B KNL1 PPP6R3 | 1.63e-03 | 1347 | 138 | 15 | EFO_0005192 |
| Disease | C-C motif chemokine 19 measurement | 1.90e-03 | 14 | 138 | 2 | EFO_0008047 | |
| Disease | macula measurement | 1.99e-03 | 189 | 138 | 5 | EFO_0008375 | |
| Disease | parental longevity | 2.33e-03 | 494 | 138 | 8 | EFO_0007796 | |
| Disease | Abnormal behavior | 2.50e-03 | 16 | 138 | 2 | C0233514 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 2.50e-03 | 16 | 138 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | creatinine measurement | KLF8 GAPVD1 DNAJC13 SIPA1L3 DAB2 NPLOC4 AREG IGF1R ZZZ3 MTMR3 BSN MRTFA | 2.53e-03 | 995 | 138 | 12 | EFO_0004518 |
| Disease | platelet component distribution width | 2.98e-03 | 755 | 138 | 10 | EFO_0007984 | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 3.09e-03 | 62 | 138 | 3 | EFO_0803360, EFO_0803362 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 3.39e-03 | 131 | 138 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 3.39e-03 | 131 | 138 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 3.39e-03 | 131 | 138 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 3.39e-03 | 131 | 138 | 4 | C3714758 | |
| Disease | Global developmental delay | 3.58e-03 | 133 | 138 | 4 | C0557874 | |
| Disease | keratoconus | 3.69e-03 | 66 | 138 | 3 | MONDO_0015486 | |
| Disease | Juvenile-Onset Still Disease | 3.78e-03 | 135 | 138 | 4 | C0087031 | |
| Disease | corneal hysteresis | 3.90e-03 | 20 | 138 | 2 | EFO_0010066 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 3.98e-03 | 137 | 138 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | bipolar I disorder | 4.41e-03 | 141 | 138 | 4 | EFO_0009963 | |
| Disease | systemic lupus erythematosus | TMEM116 PHRF1 DAB2 SRCAP GTF2IRD1 TASL SYNGAP1 TOX4 MTF1 ICAM5 | 4.43e-03 | 799 | 138 | 10 | MONDO_0007915 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AEDSNMSVPSEPSSP | 556 | Q13523 | |
| SEISPVSEMPSSSEP | 61 | P15514 | |
| ADPEMVTLPLQPSST | 56 | Q16611 | |
| MALPTPSDSTLPAEA | 1 | P0CJ87 | |
| PPVTTHNMIDDSTDP | 441 | P54840 | |
| VTSPSSDEPPMEASQ | 81 | Q13541 | |
| ASSPAIDMPPQSETI | 311 | Q8IZP9 | |
| NVDSSPETSPSVSPM | 941 | Q8TDJ6 | |
| MALPTPSDSTLPAEA | 1 | P0CJ89 | |
| EAESMPPPRTSASSV | 431 | Q9C0C7 | |
| PTPSMQDGLDLPSET | 66 | Q9UK58 | |
| SSIPSALPEPMTASE | 331 | Q9NSY1 | |
| PVSNLPLTSETSPMS | 706 | Q9C0F0 | |
| PLTSETSPMSDLPLT | 711 | Q9C0F0 | |
| NTPEPIIMSSSSIAP | 806 | Q9C0F0 | |
| ADTFNEMQPPSSEPS | 311 | P54802 | |
| EAMPEPTVSPVNASD | 201 | Q8TD07 | |
| QSTSSEEMVPSSPSP | 66 | P13631 | |
| TFPEPPMLLTSDQTL | 411 | O60393 | |
| PEIAMTSLTSPIPEN | 291 | Q96TA0 | |
| TSLTSPIPENSSPEM | 296 | Q96TA0 | |
| PSEAPASLSLMPSDL | 641 | Q9HCM3 | |
| FGDMSTPPDLNSPTE | 216 | P98082 | |
| DSTSTGELQPMPTSP | 41 | P33991 | |
| DMLDTSLEPVTTSPP | 8896 | Q8WXI7 | |
| LTLSPGEPETTPSMA | 10896 | Q8WXI7 | |
| LTLSPGEPETTPSMA | 11006 | Q8WXI7 | |
| DDFPTSVPDLSTPML | 831 | P43146 | |
| ASSEMPAPPQESTEN | 91 | O60309 | |
| APALPPESSMESLTL | 261 | O60309 | |
| PSDMQDSSLSHKIPP | 1691 | P46821 | |
| MSTPTLEEEPASNPA | 396 | Q71F56 | |
| PSTTRPLNSVEPATM | 1086 | Q71F56 | |
| MALPTPSDSTLPAEA | 1 | Q9UBX2 | |
| ASSEMPAPPQESTEN | 91 | A6NM11 | |
| APALPPESSMESLTL | 261 | A6NM11 | |
| ASSEMPAPPQESTEN | 91 | A6NMS7 | |
| APALPPESSMESLTL | 261 | A6NMS7 | |
| EMPSEDSLAEPVPTS | 1096 | Q9HCH0 | |
| TSEMLPDSDPAPAVT | 116 | Q99607 | |
| PPTESRMSVSSDPDP | 301 | Q9UQF2 | |
| STEESSPQDQPPVMR | 491 | O15327 | |
| TDMSTIPPSASLNLP | 3036 | Q2LD37 | |
| SPPSQSESLLAMFDP | 816 | Q14C86 | |
| TPEEMSNLTPESSPE | 501 | Q8IWQ3 | |
| PMRSQASEEESPVSP | 3496 | Q9UPA5 | |
| ADELDDSKPPPSSSM | 801 | Q14118 | |
| MALPTPSDSTLPAEA | 1 | P0CJ86 | |
| EPENMESVPLDPSAS | 1296 | P08069 | |
| SDITELAPASPMASP | 266 | Q00613 | |
| DLFSPSVTVPDMSLP | 416 | Q00613 | |
| ESLESFSSMPDPVDP | 1256 | Q15154 | |
| SAESPPEMDESTCPS | 661 | Q9UMF0 | |
| SSSPVPTLSPEQQEM | 556 | Q9UBU9 | |
| VSIDPTMPANSERTP | 61 | O76083 | |
| METLPLESQTHPTSP | 866 | Q6ZU69 | |
| SQMEDPSTSPSPGTR | 296 | Q9UI08 | |
| SLAGPSSEMETSVPP | 81 | Q8TAT6 | |
| NTPETTMPPSEATTP | 116 | Q8N687 | |
| EATTPETTMPPSETA | 126 | Q8N687 | |
| PSETATSETMPPPSQ | 136 | Q8N687 | |
| SVLEPSMSSPSDIDS | 326 | Q99550 | |
| NDAETMSVDSSLPSP | 266 | P09086 | |
| IQLDDMSSPPSPEST | 1281 | Q9P1Y6 | |
| TSMSPLEIPSDSEES | 221 | O95600 | |
| IEMPTLSSSPTEERP | 736 | Q7LBC6 | |
| FTVNTPPTPEDLMLS | 1921 | Q8NG31 | |
| QEAPALPPESSMESL | 301 | Q96QE4 | |
| LPPESSMESLAQTPL | 306 | Q96QE4 | |
| PMVPPTSDRSQESSA | 1371 | Q6ZVL6 | |
| SQDEDPSLSPDMPIT | 486 | Q5JSP0 | |
| MSNPSPQVPEEEAST | 1 | Q9UBC1 | |
| SMPTVSFLDQDQSPP | 1191 | A7KAX9 | |
| EESPMDVDQPSPSAQ | 3806 | Q7Z6Z7 | |
| PTTDPQASLSPMSES | 166 | Q9HCI7 | |
| MELDLSPPHLSSSPE | 1 | Q14451 | |
| PPVLSSDPNMLSNEE | 1001 | O75694 | |
| SASMPETTATEPQPD | 471 | O75864 | |
| ESPQNPSSSPLAEMA | 1116 | Q14686 | |
| FDTMSPAPVIPSNTD | 106 | O15350 | |
| PASLEFLPMESPTAV | 786 | Q9NQ11 | |
| QPESPVLLPATEMAS | 61 | Q5TZA2 | |
| LTSDSPPHNDIMTPV | 466 | Q12778 | |
| MESIPATSEAASPPA | 1231 | Q4G0P3 | |
| SQPEDSVPTPDEVSM | 1846 | Q9P2D3 | |
| AAATPEPAMAQPDST | 456 | Q8NCB2 | |
| AQPSSSTDPSIMEPT | 331 | Q14209 | |
| STDPSIMEPTASSVP | 336 | Q14209 | |
| MALPTPSDSTLPAEA | 1 | Q6RFH8 | |
| PPSSSSQDEELLMPP | 796 | Q5T3F8 | |
| SSDMSLSEPPQPLAR | 711 | Q5VT06 | |
| TPTPTEAAPMPETSE | 311 | P20908 | |
| MALPTPSDSTLPAEA | 1 | P0CJ90 | |
| LISTPPSDMLPTTEG | 541 | Q9P203 | |
| STSVMSNLPPPVDHE | 2221 | O75165 | |
| EESEPMDTSPIPTSP | 151 | Q15723 | |
| MDTSPIPTSPDSHEP | 156 | Q15723 | |
| MPPDSSSPENKSLEV | 146 | Q9NWZ3 | |
| MALPTPSDSTLPAEA | 1 | P0CJ88 | |
| VTVPDPSPTSEEMTD | 506 | Q9UHL9 | |
| EESATVSAPAPMSPT | 171 | Q9BWG6 | |
| SDMAVSTPASEPQPD | 296 | Q5SV97 | |
| STPASEPQPDRDMAV | 301 | Q5SV97 | |
| EPQPDRDMAVSTPAS | 306 | Q5SV97 | |
| RDMAVSTPASEPQPD | 326 | Q5SV97 | |
| STPASEPQPDTDMAV | 331 | Q5SV97 | |
| EPQPDTDMAVSTPAS | 336 | Q5SV97 | |
| TDMAVSTPASEPQPD | 341 | Q5SV97 | |
| STPASEPQPDRDMAV | 346 | Q5SV97 | |
| QASPMPVDSVEADPT | 581 | Q5VV67 | |
| MDPTPEASEPSTSQG | 471 | Q6ZNG9 | |
| LPQTMEPSPSETSLV | 876 | Q13615 | |
| LSSQLPDTPNSMVPS | 341 | Q96A47 | |
| VEMDPSTEATSPPTT | 701 | Q9H195 | |
| PVMVPDSAVASDNSP | 276 | Q9UBD0 | |
| STPLMLAPDSGELSP | 191 | Q8NET4 | |
| SSDPEVLTLSMAVPP | 416 | Q9BYJ4 | |
| SSNEPENRVLPMPTS | 651 | Q9NQ86 | |
| ENPPSNMSPDTLALF | 751 | P0C7P3 | |
| PLSSLLPSASVPESM | 451 | Q8TEQ0 | |
| ASPPNTDELMSRSQP | 371 | Q9NYJ8 | |
| AETPSDPQTETLSAM | 701 | Q14872 | |
| VNPMDSTVTPAPSDA | 826 | O14594 | |
| SDIEEMTDSSLPSSP | 1856 | Q8IVL1 | |
| RTTPTMSEEPPLDLT | 1701 | O60292 | |
| PLMSSSEEEFSPPQS | 211 | Q15475 | |
| EDTGLSMPSDTSLSP | 621 | Q93073 | |
| DMPLEEPSSSSVPSA | 2211 | Q6ZRS2 | |
| TTSMPAPTTTTPEEE | 1551 | A1L4H1 | |
| TPEPTEMQSPSTREI | 556 | E7EW31 | |
| DFLSLPIMVPPDTST | 791 | Q9NZP6 | |
| TAILDHPPSPMDTSE | 851 | Q969V6 | |
| LQMPESEGPSSLDPS | 356 | Q13501 | |
| DSAEQLSSPMPSATP | 1136 | Q9UPX8 | |
| PSLELESTSETSDMP | 546 | Q8TE77 | |
| SDSDKSTEDPPMDLP | 956 | P55201 | |
| PPMQLDSTSAEDTSP | 216 | Q6UXG3 | |
| FPSNPSLMDSENPSD | 116 | Q7LFX5 | |
| TSQEDPKESPAMLPT | 906 | Q15021 | |
| PSSTPITPAMPLDED | 731 | Q9HCE3 | |
| APRETPSEMATNSLP | 1001 | Q5TCY1 | |
| DMLTPTPDSSPRSTS | 1846 | O60673 | |
| SQDPERSSPPMLSAD | 6 | Q9C0H9 | |
| PSTLNPTMPASERTV | 1141 | Q96PV0 | |
| IPLPMEDSISTQPSD | 161 | Q9HAI6 | |
| DPAGEETMSPTSPTL | 1341 | Q9HCF6 | |
| DSSPPEVSGPSSSQM | 736 | O75152 | |
| TPAAEETMNTSPGTP | 161 | O14798 | |
| PSAMAELPPSANTSV | 66 | Q8NCL8 | |
| SEPNPDDPLMADISS | 116 | Q9NPD8 | |
| THDMEPSTPDTPKES | 561 | Q9UBS9 | |
| AAMSLQEEAEPTPSP | 2016 | Q96JG9 | |
| VDPPSLMATSDPPQS | 656 | P98168 | |
| MSSEVGSTASDEPPP | 1486 | O60346 | |
| PMDIVPPSEDSNSQD | 116 | Q8TF01 | |
| NMTPSDPLQTSLSPE | 191 | Q8N680 | |
| PPNTLMELSLEPADS | 201 | A0PK05 | |
| PVEPISNSEPSMNSD | 621 | Q9HBM0 | |
| ESPEMTSLPPATLEA | 141 | Q9H8Y1 | |
| SMPDDVFESPPLSAS | 301 | Q6PJF5 | |
| TSTEPMDPLTPSAAA | 746 | Q5H9R7 | |
| TSLESMPASGEPEPS | 341 | Q8IYH5 | |
| ESILEPPAMAAPESS | 1341 | P18583 | |
| LEETPEAPVPTNMST | 1251 | Q63HR2 | |
| TVESSPERPMNNSPE | 511 | O94842 | |
| ISPSSRNPASVEPTM | 1521 | Q562E7 | |
| EDSSPSLLLSMTVPP | 416 | Q9C030 | |
| SEDFSPLSPDVPMTV | 896 | Q7Z3T8 | |
| PSLPTPDMSSEVLED | 56 | Q9H0D2 | |
| PTTPTEETTTSMEEP | 661 | Q9Y493 | |
| TTASPETPELDMAAP | 196 | Q8TEU8 | |
| MALPTPSDSTLPAEA | 1 | P0CJ85 | |
| AEPLSPAMSISPQAT | 276 | Q9P206 | |
| AMTPPLPLQDTDLSS | 601 | O15069 | |
| AMTPPLPLQDTDLSS | 681 | O15069 | |
| AMTPPLPLQDTDLSS | 721 | O15069 | |
| AMTPPLPLQDTDLSS | 761 | O15069 | |
| AMTPPLPLQDTDLSS | 801 | O15069 | |
| AMTPPLPLQDTDLSS | 841 | O15069 | |
| AMTPPLPLQDTDLSS | 881 | O15069 |